Biodegradable polymer nanogels for drug/nucleic acid delivery

Chemical Reviews

Volumn 115, Issue 16, 2015, Pages 8564-8608

  Li, Yulin ^a,b   Maciel, Dina ^a   Rodrigues, João ^a   Shi, Xiangyang ^a,c   Tomás, Helena ^a  

^a UNIVERSITY OF MADEIRA   (Portugal)

^b EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c DONGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADABILITY; BIODEGRADABLE POLYMERS; CHEMICAL MODIFICATION; CONTROLLED DRUG DELIVERY; DRUG INTERACTIONS; NANOSTRUCTURED MATERIALS; NATURAL POLYMERS;

BIOLOGICAL SIGNALING; DEGRADABILITY; INTRACELLULAR UPTAKE; STIMULI-SENSITIVE; SYNTHETIC POLYMERS; TARGETING LIGANDS; THERAPEUTIC EFFICACY; WELL-DEFINED STRUCTURES;

TARGETED DRUG DELIVERY;

DNA; DRUG CARRIER; GEL; NANOMATERIAL; POLYMER; RNA;

ANIMAL; CHEMISTRY; GEL; HUMAN; METABOLISM; SYNTHESIS;

ANIMALS; DNA; DRUG CARRIERS; GELS; HUMANS; NANOSTRUCTURES; POLYMERS; RNA;

EID: 84940488356     PISSN: 00092665     EISSN: 15206890     Source Type: Journal    
DOI: 10.1021/cr500131f     Document Type: Review

References (368)

1. Torchilin, V. P. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. Biopolymers 2008, 90, 604-610.
2. Bildstein, L.; Dubernet, C.; Couvreur, P. Prodrug-based intracellular delivery of anticancer agents. Adv. Drug Delivery Rev. 2011, 63, 3-23.
3. Reischl, D.; Zimmer, A. Drug delivery of siRNA therapeutics: potentials and limits of nanosystems. Nanomedicine 2009, 5, 8-20.
4. Juliano, R. L.; Ming, X.; Nakagawa, O. Cellular Uptake and Intracellular Trafficking of Antisense and siRNA Oligonucleotides. Bioconjugate Chem. 2012, 23, 147-157.
5. Toita, S.; Sawada, S.; Akiyoshi, K. Polysaccharide nanogel gene delivery system with endosome-escaping function: Co-delivery of plasmid DNA and phospholipase A(2). J. Controlled Release 2011, 155, 54-59.
6. Chen, G. Y.; Qiu, H. L.; Prasad, P. N.; Chen, X. Y. Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics. Chem. Rev. 2014, 114, 5161-5214.
7. Mahmoudi, M.; Hofmann, H.; Rothen-Rutishauser, B.; Petri- Fink, A. Assessing the In Vitro and In Vivo Toxicity of Superparamagnetic Iron Oxide Nanoparticles. Chem. Rev. 2012, 112, 2323-2338.
8. O'Driscoll, C. M.; Griffin, B. T. Biopharmaceutical challenges associated with drugs with low aqueous solubility - The potential impact of lipid-based formulations. Adv. Drug Delivery Rev. 2008, 60, 617-624.
9. Tan, J. P.; Wang, Q.; Tam, K. C. Control of burst release from nanogels via layer by layer assembly. J. Controlled Release 2008, 128, 248-254.
10. Astashkina, A.; Mann, B.; Grainger, D. W. A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity. Pharmacol. Ther. 2012, 134, 82-106.
11. Yin, Q.; Shen, J.; Zhang, Z.; Yu, H.; Li, Y. Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor. Adv. Drug Delivery Rev. 2013, 65, 1699-1715.
12. van der Aa, M. A. E. M.; Mastrobattista, E.; Oosting, R. S.; Hennink, W. E.; Koning, G. A.; Crommelin, D. J. A. The nuclear pore complex: The gateway to successful nonviral gene delivery. Pharm. Res. 2006, 23, 447-459.
13. Mastrobattista, E.; van der Aa, M. A. E. M.; Hennink, W. E.; Crommelin, D. J. A. Artificial viruses: a nanotechnological approach to gene delivery. Nat. Rev. Drug Discovery 2006, 5, 115-121.
14. Wong, H. L.; Wu, X. Y.; Bendayan, R. Nanotechnological advances for the delivery of CNS therapeutics. Adv. Drug Delivery Rev. 2012, 64, 686-700.
15. Mastrobattista, E.; Hennink, W. E.; Schiffelers, R. M. Delivery of nucleic acids. Pharm. Res. 2007, 24, 1561-1563.
16. Panyam, J.; Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Delivery Rev. 2012, 64, 61-71.
17. Couvreur, P. Nanoparticles in drug delivery: Past, present and future. Adv. Drug Delivery Rev. 2013, 65, 21-23.
18. Bourzac, K. Nanotechnology: Carrying drugs. Nature 2012, 491, S58-860.
19. Xu, S.; Olenyuk, B. Z.; Okamoto, C. T.; Hamm-Alvarez, S. F. Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances. Adv. Drug Delivery Rev. 2013, 65, 121-138.
20. Grull, H.; Langereis, S. Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound. J. Controlled Release 2012, 161, 317-327.
21. Endres, T. K.; Beck-Broichsitter, M.; Samsonova, O.; Renette, T.; Kissel, T. H. Self-assembled biodegradable amphiphilic PEG-PCLlPEI triblock copolymers at the borderline between micelles and nanoparticles designed for drug and gene delivery. Biomaterials 2011, 32, 7721-7731.
22. Medina, S. H.; Tekumalla, V.; Chevliakov, M. V.; Shewach, D. S.; Ensminger, W. D.; El-Sayed, M. E. H. N-acetylgalactosaminefunctionalized dendrimers as hepatic cancer cell-targeted carriers. Biomaterials 2011, 32, 4118-4129.
23. Shan, Y. B.; Luo, T.; Peng, C.; Sheng, R. L.; Cao, A. M.; Cao, X. Y.; Shen, M. W.; Guo, R.; Tomás, H.; Shi, X. Y. Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors. Biomaterials 2012, 33, 3025-3035.
24. Luo, Y.; Ling, Y.; Guo, W. S.; Pang, J.; Liu, W. P.; Fang, Y. Q.; Wen, X. Q.; Wei, K.; Gao, X. Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells. J. Controlled Release 2010, 147, 278-288.
25. Feazell, R. P.; Nakayama-Ratchford, N.; Dai, H.; Lippard, S. J. Soluble single-walled carbon nanotubes as longboat delivery systems for Platinum(IV) anticancer drug design. J. Am. Chem. Soc. 2007, 129, 8438-8439.
26. Prakash, S.; Malhotra, M.; Shao, W.; Tomaro-Duchesneau, C.; Abbasi, S. Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy. Adv. Drug Delivery Rev. 2011, 63, 1340-1351.
27. Doane, T.; Burda, C. Nanoparticle mediated non-covalent drug delivery. Adv. Drug Delivery Rev. 2013, 65, 607-621.
28. Oh, J. K.; Drumright, R.; Siegwart, D. J.; Matyjaszewski, K. The development of microgels/nanogels for drug delivery applications. Prog. Polym. Sci. 2008, 33, 448-477.
29. Kabanov, A. V.; Vinogradov, S. V. Nanogels as Pharmaceutical Carriers: Finite Networks of Infinite Capabilities. Angew. Chem., Int. Ed. 2009, 48, 5418-5429.
30. Kopeček, J. Hydrogel biomaterials: A smart future? Biomaterials 2007, 28, 5185-5192.
31. Hamidi, M.; Azadi, A.; Rafiei, P. Hydrogel nanoparticles in drug delivery. Adv. Drug Delivery Rev. 2008, 60, 1638-1649.
32. Ryu, J. H.; Jiwpanich, S.; Chacko, R.; Bickerton, S.; Thayumanavan, S. Surface-Functionalizable Polymer Nanogels with Facile Hydrophobic Guest Encapsulation Capabilities. J. Am. Chem. Soc. 2010, 132, 8246-8247.
33. Moya-Ortega, M. D.; Alvarez-Lorenzo, C.; Concheiro, A.; Loftsson, T. Cyclodextrin-based nanogels for pharmaceutical and biomedical applications. Int. J. Pharm. 2012, 428, 152-163.
34. McAllister, K.; Sazani, P.; Adam, M.; Cho, M. J.; Rubinstein, M.; Samulski, R. J.; DeSimone, J. M. Polymeric nanogels produced via inverse microemulsion polymerization as potential gene and antisense delivery agents. J. Am. Chem. Soc. 2002, 124, 15198-15207.
35. Ramos, J.; Forcada, J.; Hidalgo-Alvarez, R. Cationic Polymer Nanoparticles and Nanogels: From Synthesis to Biotechnological Applications. Chem. Rev. 2014, 114, 367-428.
36. Yallapu, M. M.; Jaggi, M.; Chauhan, S. C. Design and engineering of nanogels for cancer treatment. Drug Discovery Today 2011, 16, 457-463.
37. Yan, L. S.; Yang, L. X.; He, H. Y.; Hu, X. L.; Xie, Z. G.; Huang, Y. B.; Jing, X. B. Photo-cross-linked mPEG-poly(gamma-cinnamyl-Lglutamate) micelles as stable drug carriers. Polym. Chem. 2012, 3, 1300-1307.
38. Park, S. Y.; Baik, H. J.; Oh, Y. T.; Oh, K. T.; Youn, Y. S.; Lee, E. S. A Smart Polysaccharide/Drug Conjugate for Photodynamic Therapy. Angew. Chem., Int. Ed. 2011, 50, 1644-1647.
39. Choi, W. I.; Lee, J. H.; Kim, J. Y.; Kim, J. C.; Kim, Y. H.; Tae, G. Efficient skin permeation of soluble proteins via flexible and functional nano-carrier. J. Controlled Release 2012, 157, 272-278.
40. Beningo, K. A.; Wang, Y. L. Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. J. Cell Sci. 2002, 115, 849-856.
41. Hasegawa, U.; Nomura, S. I. M.; Kaul, S. C.; Hirano, T.; Akiyoshi, K. Nanogel-quantum dot hybrid nanoparticles for live cell imaging. Biochem. Biophys. Res. Commun. 2005, 331, 917-921.
42. Ahmad, Z.; Pandey, R.; Sharma, S.; Khuller, G. K. Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two doses. Int. J. Antimicrob. Agents 2006, 27, 409-416.
43. Yoo, J. W.; Doshi, N.; Mitragotri, S. Adaptive micro and nanoparticles: Temporal control over carrier properties to facilitate drug delivery. Adv. Drug Delivery Rev. 2011, 63, 1247-1256.
44. Cao, L.; Mooney, D. J. Spatiotemporal control over growth factor signaling for therapeutic neovascularization. Adv. Drug Delivery Rev. 2007, 59, 1340-1350.
45. Vinogradov, S. V. Polymeric nanogel formulations of nucleoside analogs. Expert Opin. Drug Delivery 2007, 4, 5-17.
46. Luo, S. L.; Zhang, E. L.; Su, Y. P.; Cheng, T. M.; Shi, C. M. A review of NIR dyes in cancer targeting and imaging. Biomaterials 2011, 32, 7127-7138.
47. Chacko, R. T.; Ventura, J.; Zhuang, J.; Thayumanavan, S. Polymer nanogels: A versatile nanoscopic drug delivery platform. Adv. Drug Delivery Rev. 2012, 64, 836-851.
48. de la Fuente, M.; Ravina, M.; Paolicelli, P.; Sanchez, A.; Seijo, B.; Alonso, M. J. Chitosan-based nanostructures: A delivery platform for ocular therapeutics. Adv. Drug Delivery Rev. 2010, 62, 100-117.
49. Delair, T. Colloidal polyelectrolyte complexes of chitosan and dextran sulfate towards versatile nanocarriers of bioactive molecules. Eur. J. Pharm. Biopharm. 2011, 78, 10-18.
50. Douglas, K. L.; Piccirillo, C. A.; Tabrizian, M. Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles. J. Controlled Release 2006, 115, 354-361.
51. Huang, Y.; Lapitsky, Y. Monovalent Salt Enhances Colloidal Stability during the Formation of Chitosan/Tripolyphosphate Microgels. Langmuir 2011, 27, 10392-10399.
52. Schmitt, F.; Lagopoulos, L.; Kauper, P.; Rossi, N.; Busso, N.; Barge, J.; Wagnieres, G.; Laue, C.; Wandrey, C.; Juillerat-Jeanneret, L. Chitosan-based nanogels for selective delivery of photosensitizers to macrophages and improved retention in and therapy of articular joints. J. Controlled Release 2010, 144, 242-250.
53. Schutz, C. A.; Juillerat-Jeanneret, L.; Kauper, P.; Wandrey, C. Cell Response to the Exposure to Chitosan-TPP/Alginate Nanogels. Biomacromolecules 2011, 12, 4153-4161.
54. Jonassen, H.; Kjoniksen, A. L.; Hiorth, M. Stability of chitosan nanoparticles cross-linked with tripolyphosphate. Biomacromolecules 2012, 13, 3747-3756.
55. Sarmento, B.; Ribeiro, A. J.; Veiga, F.; Ferreira, D. C.; Neufeld, R. J. Insulin-loaded nanoparticles are prepared by alginate ionotropic pre-gelation followed by chitosan polyelectrolyte complexation. J. Nanosci. Nanotechnol. 2007, 7, 2833-2841.
56. Maciel, D.; Figueira, P.; Xiao, S.; Hu, D.; Shi, X.; Rodrigues, J.; Tomás, H.; Li, Y. Redox-responsive alginate nanogels with enhanced anticancer cytotoxicity. Biomacromolecules 2013, 14, 3140-3146.
57. Brunel, F.; Veron, L.; Ladaviere, C.; David, L.; Domard, A.; Delair, T. Synthesis and structural characterization of chitosan nanogels. Langmuir 2009, 25, 8935-8943.
58. Oliveira, M. A. M.; Boyer, C.; Nele, M.; Pinto, J. C.; Zetterlund, P. B.; Davis, T. P. Synthesis of Biodegradable Hydrogel Nanoparticles for Bioapplications Using Inverse Miniemulsion RAFT Polymerization. Macromolecules 2011, 44, 7167-7175.
59. Saraogi, G. K.; Gupta, P.; Gupta, U. D.; Jain, N. K.; Agrawal, G. P. Gelatin nanocarriers as potential vectors for effective management of tuberculosis. Int. J. Pharm. 2010, 385, 143-149.
60. Giaccone, G. Twenty-five years of treating advanced NSCLC: what have we achieved? Ann. Oncol. 2004, 15, 81-83.
61. Tseng, C. L.; Su, W. Y.; Yen, K. C.; Yang, K. C.; Lin, F. H. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials 2009, 30, 3476-3485.
62. Lee, J.; Lee, C.; Kim, T. H.; Lee, E. S.; Shin, B. S.; Chi, S. C.; Park, E. S.; Lee, K. C.; Youn, Y. S. Self-assembled glycol chitosan nanogels containing palmityl-acylated exendin-4 peptide as a longacting anti-diabetic inhalation system. J. Controlled Release 2012, 161, 728-734.
63. Choi, K. Y.; Lee, S.; Park, K.; Kim, K.; Park, J. H.; Kwon, I. C.; Jeong, S. Y. Preparation and characterization of hyaluronic acid-based hydrogel nanoparticles. J. Phys. Chem. Solids 2008, 69, 1591-1595.
64. Toita, S.; Hasegawa, U.; Koga, H.; Sekiya, I.; Muneta, T.; Akiyoshi, K. Protein-conjugated quantum dots effectively delivered into living cells by a cationic nanogel. J. Nanosci. Nanotechnol. 2008, 8, 2279-2285.
65. Duan, C. X.; Zhang, D. R.; Wang, F. H.; Zheng, D. D.; Jia, L. J.; Feng, F. F.; Liu, Y.; Wang, Y. C.; Tian, K. L.; Wang, F. S.; Zhang, Q. Chitosan-g-poly(N-isopropylacrylamide) based nanogels for tumor extracellular targeting. Int. J. Pharm. 2011, 409, 252-259.
66. Elnakat, H.; Ratnam, M. Role of folate receptor genes in reproduction and related cancers. Front. Biosci., Landmark Ed. 2006, 11, 506-519.
67. Liu, Y. H.; Sun, J.; Cao, W.; Yang, J. H.; Lian, H.; Li, X.; Sun, Y. H.; Wang, Y. J.; Wang, S. L.; He, Z. G. Dual targeting folateconjugated hyaluronic acid polymeric micelles for paclitaxel delivery. Int. J. Pharm. 2011, 421, 160-169.
68. Morimoto, N.; Endo, T.; Ohtomi, M.; Iwasaki, Y.; Akiyoshi, K. Hybrid nanogels with physical and chemical cross-linking structures as nanocarriers. Macromol. Biosci. 2005, 5, 710-716.
69. Choi, W. I.; Tae, G.; Kim, Y. H. One pot, single phase synthesis of thermo-sensitive nano-carriers by photo-crosslinking of a diacrylated pluronic. J. Mater. Chem. 2008, 18, 2769-2774.
70. Asadi, H.; Rostamizadeh, K.; Salari, D.; Hamidi, M. Preparation and characterization of tri-block poly(lactide)-poly(ethylene glycol)- poly(lactide) nanogels for controlled release of naltrexone. Int. J. Pharm. 2011, 416, 356-364.
71. Chang, D.; Lei, J.; Cui, H. R.; Lu, N.; Sun, Y. J.; Zhang, X. H.; Gao, C.; Zheng, H.; Yin, Y. H. Disulfide cross-linked nanospheres from sodium alginate derivative for inflammatory bowel disease: Preparation, characterization, and in vitro drug release behavior. Carbohydr. Polym. 2012, 88, 663-669.
72. Nguyen, D. H.; Choi, J. H.; Joung, Y. K.; Park, K. D. Disulfidecrosslinked heparin-pluronic nanogels as a redox-sensitive nanocarrier for intracellular protein delivery. J. Bioact. Compat. Polym. 2011, 26, 287-300.
73. Tan, J. J.; Kang, H. L.; Liu, R. G.; Wang, D. Q.; Jin, X.; Li, Q. M.; Huang, Y. Dual-stimuli sensitive nanogels fabricated by selfassociation of thiolated hydroxypropyl cellulose. Polym. Chem. 2011, 2, 672-678.
74. Li, Y. L.; Rodrigues, J.; Tomás, H. Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications. Chem. Soc. Rev. 2012, 41, 2193-2221.
75. Kumar, M. N. V. R.; Muzzarelli, R. A. A.; Muzzarelli, C.; Sashiwa, H.; Domb, A. J. Chitosan chemistry and pharmaceutical perspectives. Chem. Rev. 2004, 104, 6017-6084.
76. Mizrahy, S.; Peer, D. Polysaccharides as building blocks for nanotherapeutics. Chem. Soc. Rev. 2012, 41, 2623-2640.
77. Balakrishnan, B.; Banerjee, R. Biopolymer-Based Hydrogels for Cartilage Tissue Engineering. Chem. Rev. 2011, 111, 4453-4474.
78. Pawar, S. N.; Edgar, K. J. Alginate derivatization: A review of chemistry, properties and applications. Biomaterials 2012, 33, 3279-3305.
79. Ma, D.; Tu, K.; Zhang, L. M. Bioactive Supramolecular Hydrogel with Controlled Dual Drug Release Characteristics. Biomacromolecules 2010, 11, 2204-2212.
80. Tully, S. E.; Mabon, R.; Gama, C. I.; Tsai, S. M.; Liu, X. W.; Hsieh-Wilson, L. C. A chondroitin sulfate small molecule that stimulates neuronal growth. J. Am. Chem. Soc. 2004, 126, 7736-7737.
81. Higuchi, A.; Ling, Q. D.; Hsu, S. T.; Umezawa, A. Biomimetic Cell Culture Proteins as Extracellular Matrices for Stem Cell Differentiation. Chem. Rev. 2012, 112, 4507-4540.
82. Yamaguchi, N.; Zhang, L.; Chae, B. S.; Palla, C. S.; Furst, E. M.; Kiick, K. L. Growth factor mediated assembly of cell receptorresponsive hydrogels. J. Am. Chem. Soc. 2007, 129, 3040-3041.
83. Chen, T. H.; Small, D. A.; McDermott, M. K.; Bentley, W. E.; Payne, G. F. Enzymatic methods for in situ cell entrapment and cell release. Biomacromolecules 2003, 4, 1558-1563.
84. Pike, D. B.; Cai, S. S.; Pomraning, K. R.; Firpo, M. A.; Fisher, R. J.; Shu, X. Z.; Prestwich, G. D.; Peattie, R. A. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 2006, 27, 5242-5251.
85. Allison, D. D.; Grande-Allen, K. J. Review. Hyaluronan: A powerful tissue engineering tool. Tissue Eng. 2006, 12, 2131-2140.
86. Jha, A. K.; Xu, X. A.; Duncan, R. L.; Jia, X. Q. Controlling the adhesion and differentiation of mesenchymal stem cells using hyaluronic acid-based, doubly crosslinked networks. Biomaterials 2011, 32, 2466-2478.
87. Zhu, J. M. Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering. Biomaterials 2010, 31, 4639-4656.
88. Garcia-Fuentes, M.; Alonso, M. J. Chitosan-based drug nanocarriers: Where do we stand? J. Controlled Release 2012, 161, 496-504.
89. Liu, X. H.; Holzwarth, J. M.; Ma, P. X. Functionalized Synthetic Biodegradable Polymer Scaffolds for Tissue Engineering. Macromol. Biosci. 2012, 12, 911-919.
90. Hasegawa, U.; Sawada, S.; Shimizu, T.; Kishida, T.; Otsuji, E.; Mazda, O.; Akiyoshi, K. Raspberry-like assembly of cross-linked nanogels for protein delivery. J. Controlled Release 2009, 140, 312-317.
91. De Souza, R.; Zahedi, P.; Allen, C. J.; Piquette-Miller, M. Biocompatibility of injectable chitosan-phospholipid implant systems. Biomaterials 2009, 30, 3818-3824.
92. Bhattarai, N.; Gunn, J.; Zhang, M. Q. Chitosan-based hydrogels for controlled, localized drug delivery. Adv. Drug Delivery Rev. 2010, 62, 83-99.
93. Goycoolea, F. M.; Lollo, G.; Remunan-Lopez, C.; Quaglia, F.; Alonso, M. J. Chitosan-Alginate Blended Nanoparticles as Carriers for the Transmucosal Delivery of Macromolecules. Biomacromolecules 2009, 10, 1736-1743.
94. Jayakumar, R.; Nair, A.; Rejinold, N. S.; Maya, S.; Nair, S. V. Doxorubicin-loaded pH-responsive chitin nanogels for drug delivery to cancer cells. Carbohydr. Polym. 2012, 87, 2352-2356.
95. Makhlof, A.; Werle, M.; Tozuka, Y.; Takeuchi, H. Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin. Int. J. Pharm. 2010, 397, 92-95.
96. Demoulins, T.; Bassi, I.; Thomann-Harwood, L.; Jandus, C.; Kaeuper, P.; Simon, H. U.; von Gunten, S.; McCullough, K. C. Alginate-coated chitosan nanogel capacity to modulate the effect of TLR ligands on blood dendritic cells. Nanomedicine 2013, 9, 806-817.
97. Morris, G. A.; Castile, J.; Smith, A.; Adams, G. G.; Harding, S. E. The effect of prolonged storage at different temperatures on the particle size distribution of tripolyphosphate (TPP) - chitosan nanoparticles. Carbohydr. Polym. 2011, 84, 1430-1434.
98. Huang, Y.; Lapitsky, Y. Salt-assisted mechanistic analysis of chitosan/tripolyphosphate micro- and nanogel formation. Biomacromolecules 2012, 13, 3868-3876.
99. Azadi, A.; Hamidi, M.; Khoshayand, M. R.; Amini, M.; Rouini, M. R. Preparation and optimization of surface-treated methotrexateloaded nanogels intended for brain delivery. Carbohydr. Polym. 2012, 90, 462-471.
100. Nasti, A.; Zaki, N. M.; de Leonardis, P.; Ungphaiboon, S.; Sansongsak, P.; Rimoli, M. G.; Tirelli, N. Chitosan/TPP and Chitosan/TPP-hyaluronic Acid Nanoparticles: Systematic Optimisation of the Preparative Process and Preliminary Biological Evaluation. Pharm. Res. 2009, 26, 1918-1930.
101. Gwak, S. J.; Jung, J. K.; An, S. S.; Kim, H. J.; Oh, J. S.; Pennant, W. A.; Lee, H. Y.; Kong, M. H.; Kim, K. N.; Yoon, D. H.; Ha, Y. Chitosan/TPP-Hyaluronic Acid Nanoparticles: A New Vehicle for Gene Delivery to the Spinal Cord. J. Biomater. Sci., Polym. Ed. 2012, 23, 1437-1450.
102. Jin, H. Q.; Tan, H.; Zhao, L. L.; Sun, W. P.; Zhu, L. J.; Sun, Y. G.; Hao, H. J.; Xing, H. Y.; Liu, L. L.; Qu, X. Z.; Huang, Y. N.; Yang, Z. Z. Ultrasound-triggered thrombolysis using urokinase-loaded nanogels. Int. J. Pharm. 2012, 434, 384-390.
103. Yong, C. P.; Gan, L. M. Microemulsion polymerizations and reactions. Adv. Polym. Sci. 2005, 175, 257-298.
104. Pujana, M. A.; Perez-Alvarez, L.; Cesteros Iturbe, L. C.; Katime, I. Water dispersible pH-responsive chitosan nanogels modified with biocompatible crosslinking-agents. Polymer 2012, 53, 3107-3116.
105. Cheng, S. H.; Liao, W. N.; Chen, L. M.; Lee, C. H. pHcontrollable release using functionalized mesoporous silica nanoparticles as an oral drug delivery system. J. Mater. Chem. 2011, 21, 7130-7137.
106. Cheng, R.; Meng, F. H.; Deng, C.; Klok, H. A.; Zhong, Z. Y. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials 2013, 34, 3647-3657.
107. Vander Heiden, M. G.; Cantley, L. C.; Thompson, C. B. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Science 2009, 324, 1029-1033.
108. Han, J. Y.; Burgess, K. Fluorescent Indicators for Intracellular pH. Chem. Rev. 2010, 110, 2709-2728.
109. Song, J. Y.; Cha, J.; Lee, J.; Roe, J. H. Glutathione reductase and a mitochondrial thioredoxin play overlapping roles in maintaining iron-sulfur enzymes in fission yeast. Eukaryotic Cell 2006, 5, 1857-1865.
110. Cheng, R.; Feng, F.; Meng, F. H.; Deng, C.; Feijen, J.; Zhong, Z. Y. Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. J. Controlled Release 2011, 152, 2-12.
111. Russo, A.; Degraff, W.; Friedman, N.; Mitchell, J. B. Selective Modulation of Glutathione Levels in Human Normal Versus Tumor- Cells and Subsequent Differential Response to Chemotherapy Drugs. Cancer Res. 1986, 46, 2845-2848.
112. Baik, H. J.; Oh, N. M.; Oh, Y. T.; Yoo, N. Y.; Park, S. Y.; Oh, K. T.; Youn, Y. S.; Lee, E. S. 3-Diethylaminopropyl-bearing glycol chitosan as a protein drug carrier. Colloids Surf., B 2011, 84, 585-590.
113. Oh, N. M.; Oh, K. T.; Baik, H. J.; Lee, B. R.; Lee, A. H.; Youn, Y. S.; Lee, E. S. A self-organized 3-diethylaminopropyl-bearing glycol chitosan nanogel for tumor acidic pH targeting: In vitro evaluation. Colloids Surf., B 2010, 78, 120-126.
114. Carvalho, C.; Santos, R. X.; Cardoso, S.; Correia, S.; Oliveira, P. J.; Santos, M. S.; Moreira, P. I. Doxorubicin: The Good, the Bad and the Ugly Effect. Curr. Med. Chem. 2009, 16, 3267-3285.
115. Zheng, H.; Zhang, X. Q.; Yin, Y. H.; Xiong, F. L.; Gong, X. Y.; Zhu, Z. J.; Lu, B.; Xu, P. H. In vitro characterization, and in vivo studies of crosslinked lactosaminated carboxymethyl chitosan nanoparticles. Carbohydr. Polym. 2011, 84, 1048-1053.
116. Kim, J. Y.; Choi, W. I.; Kim, Y. H.; Tae, G.; Lee, S. Y.; Kim, K.; Kwon, I. C. In-vivo tumor targeting of pluronic-based nano-carriers. J. Controlled Release 2010, 147, 109-117.
117. Zhou, T.; Xiao, C.; Fan, J.; Chen, S.; Shen, J.; Wu, W.; Zhou, S. A nanogel of on-site tunable pH-response for efficient anticancer drug delivery. Acta Biomater. 2013, 9, 4546-57.
118. Duan, C. X.; Gao, J.; Zhang, D. R.; Jia, L. J.; Liu, Y.; Zheng, D. D.; Liu, G. P.; Tian, X. N.; Wang, F. S.; Zhang, Q. Galactose- Decorated pH-Responsive Nanogels for Hepatoma-Targeted Delivery of Oridonin. Biomacromolecules 2011, 12, 4335-4343.
119. Ishida, S.; Sakiya, Y.; Ichikawa, T.; Taira, Z. Uptake of Glycyrrhizin by Isolated Rat Hepatocytes. Biol. Pharm. Bull. 1993, 16, 293-297.
120. Ismair, M. G.; Stanca, C.; Ha, H. R.; Renner, E. L.; Meier, P. J.; Kullak-Ublick, G. A. Interactions of glycyrrhizin with organic anion transporting polypeptides of rat and human liver. Hepatol. Res. 2003, 26, 343-347.
121. Lin, A. H.; Liu, Y. M.; Huang, Y.; Sun, J. B.; Wu, Z. F.; Zhang, M.; Ping, Q. N. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. Int. J. Pharm. 2008, 359, 247-253.
122. Ishida, S.; Sakiya, Y.; Taira, Z. Disposition of Glycyrrhizin in the Perfused Liver of Rats. Biol. Pharm. Bull. 1994, 17, 960-969.
123. Gaur, R.; Singh, R.; Gupta, M.; Gaur, M. K. Aureobasidium pullulans, an economically important polymorphic yeast with special reference to pullulan. Afr. J. Biotechnol. 2010, 9, 7989-7997.
124. Singh, R. S.; Saini, G. K.; Kennedy, J. F. Pullulan: Microbial sources, production and applications. Carbohydr. Polym. 2008, 73, 515-531.
125. Alles, N.; Soysa, N. S.; Hussain, M. D.; Tomomatsu, N.; Saito, H.; Baron, R.; Morimoto, N.; Aoki, K.; Akiyoshi, K.; Ohya, K. Polysaccharide nanogel delivery of a TNF-alpha and RANKL antagonist peptide allows systemic prevention of bone loss. Eur. J. Pharm. Sci. 2009, 37, 83-88.
126. Aoki, K.; Alles, N.; Soysa, N.; Ohya, K. Peptide-based delivery to bone. Adv. Drug Delivery Rev. 2012, 64, 1220-1238.
127. Shimizu, T.; Kishida, T.; Hasegawa, U.; Ueda, Y.; Imanishi, J.; Yamagishi, H.; Akiyoshi, K.; Otsuji, E.; Mazda, O. Nanogel DDS enables sustained release of IL-12 for tumor immunotherapy. Biochem. Biophys. Res. Commun. 2008, 367, 330-335.
128. Fujioka-Kobayashi, M.; Ota, M. S.; Shimoda, A.; Nakahama, K.; Akiyoshi, K.; Miyamoto, Y.; Iseki, S. Cholesteryl group- and acryloyl group-bearing pullulan nanogel to deliver BMP2 and FGF18 for bone tissue engineering. Biomaterials 2012, 33, 7613-7620.
129. Akiyoshi, K.; Deguchi, S.; Moriguchi, N.; Yamaguchi, S.; Sunamoto, J. Self-Aggregates of Hydrophobized Polysaccharides in Water - Formation and Characteristics of Nanoparticles. Macromolecules 1993, 26, 3062-3068.
130. Wyatt, A. R.; Yerbury, J. J.; Dabbs, R. A.; Wilson, M. R. Roles of extracellular chaperones in amyloidosis. J. Mol. Biol. 2012, 421, 499-516.
131. Inomoto, N.; Osaka, N.; Suzuki, T.; Hasegawa, U.; Ozawa, Y.; Endo, H.; Akiyoshi, K.; Shibayama, M. Interaction of nanogel with cyclodextrin or protein: Study by dynamic light scattering and smallangle neutron scattering. Polymer 2009, 50, 541-546.
132. Asayama, W.; Sawada, S. I.; Taguchi, H.; Akiyoshi, K. Comparison of refolding activities between nanogel artificial chaperone and GroEL systems. Int. J. Biol. Macromol. 2008, 42, 241-246.
133. Sawada, S.; Nomura, Y.; Aoyama, Y.; Akiyoshi, K. Heat shock protein-like activity of a nanogel artificial chaperone for citrate synthase. J. Bioact. Compat. Polym. 2006, 21, 487-501.
134. Sawada, S.; Akiyoshi, K. Nano-Encapsulation of Lipase by Self- Assembled Nanogels: Induction of High Enzyme Activity and Thermal Stabilization. Macromol. Biosci. 2010, 10, 353-358.
135. Sawada, S.; Sasaki, Y.; Nomura, Y.; Akiyoshi, K. Cyclodextrinresponsive nanogel as an artificial chaperone for horseradish peroxidase. Colloid Polym. Sci. 2011, 289, 685-691.
136. Nomura, Y.; Sasaki, Y.; Takagi, M.; Narita, T.; Aoyama, Y.; Akiyoshi, K. Thermoresponsive controlled association of protein with a dynamic nanogel of hydrophobized polysaccharide and cyclodextrin: Heat shock protein-like activity of artificial molecular chaperone. Biomacromolecules 2005, 6, 447-452.
137. Nagano, K.; Alles, N.; Mian, A. H.; Shimoda, A.; Morimoto, N.; Tamura, Y.; Shimokawa, H.; Akiyoshi, K.; Ohya, K.; Aoki, K. The tumor necrosis factor type 2 receptor plays a protective role in tumor necrosis factor-alpha-induced bone resorption lacunae on mouse calvariae. J. Bone Miner. Metab. 2011, 29, 671-681.
138. Yoshida, K.; Oida, H.; Kobayashi, T.; Maruyama, T.; Tanaka, M.; Katayama, T.; Yamaguchi, K.; Segi, E.; Tsuboyama, T.; Matsushita, M.; Ito, K.; Ito, Y.; Sugimoto, Y.; Ushikubi, F.; Ohuchida, S.; Kondo, K.; Nakamura, T.; Narumiya, S. Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 4580-4585.
139. Yang, R. S.; Liu, T. K.; Lin-Shiau, S. Y. Increased bone growth by local prostaglandin E2 in rats. Calcif. Tissue Int. 1993, 52, 57-61.
140. Kato, N.; Hasegawa, U.; Morimoto, N.; Saita, Y.; Nakashima, K.; Ezura, Y.; Kurosawa, H.; Akiyoshi, K.; Noda, M. Nanogel-based delivery system enhances PGE2 effects on bone formation. J. Cell. Biochem. 2007, 101, 1063-1070.
141. Urist, M. R. Bone: Formation by autoinduction. Clin. Orthop. Relat. Res. 2002, 395, 4-10.
142. Kamolratanakul, P.; Hayata, T.; Ezura, Y.; Kawamata, A.; Hayashi, C.; Yamamoto, Y.; Hemmi, H.; Nagao, M.; Hanyu, R.; Notomi, T.; Nakamoto, T.; Amagasa, T.; Akiyoshi, K.; Noda, M. Nanogel-Based Scaffold Delivery of Prostaglandin E-2 Receptor- Specific Agonist in Combination With a Low Dose of Growth Factor Heals Critical-Size Bone Defects in Mice. Arthritis Rheum. 2011, 63, 1021-1033.
143. Trinchieri, G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003, 3, 133-146.
144. Nochi, T.; Yuki, Y.; Takahashi, H.; Sawada, S.; Mejima, M.; Kohda, T.; Harada, N.; Kong, I. G.; Sato, A.; Kataoka, N.; Tokuhara, D.; Kurokawa, S.; Takahashi, Y.; Tsukada, H.; Kozaki, S.; Akiyoshi, K.; Kiyono, H. Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat. Mater. 2010, 9, 572-578.
145. Morris, M. C.; Depollier, J.; Mery, J.; Heitz, F.; Divita, G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 2001, 19, 1173-1176.
146. Watanabe, K.; Tsuchiya, Y.; Kawaguchi, Y.; Sawada, S.; Ayame, H.; Akiyoshi, K.; Tsubata, T. The use of cationic nanogels to deliver proteins to myeloma cells and primary T lymphocytes that poorly express heparan sulfate. Biomaterials 2011, 32, 5900-5905.
147. Boridy, S.; Takahashi, H.; Akiyoshi, K.; Maysinger, D. The binding of pullulan modified cholesteryl nanogels to A beta oligomers and their suppression of cytotoxicity. Biomaterials 2009, 30, 5583-5591.
148. Haass, C.; Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid betapeptide. Nat. Rev. Mol. Cell Biol. 2007, 8, 101-112.
149. Koffie, R. M.; Meyer-Luehmann, M.; Hashimoto, T.; Adams, K. W.; Mielke, M. L.; Garcia-Alloza, M.; Micheva, K. D.; Smith, S. J.; Kim, M. L.; Lee, V. M.; Hyman, B. T.; Spires-Jones, T. L. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 4012-4017.
150. Kobayashi, H.; Katakura, O.; Morimoto, N.; Akiyoshi, K.; Kasugai, S. Effects of Cholesterol-Bearing Pullulan (CHP)-Nanogels in Combination with Prostaglandin E1 on Wound Healing. J. Biomed. Mater. Res., Part B 2009, 91B, 55-60.
151. Akiyoshi, K.; Taniguchi, I.; Fukui, H.; Sunamoto, J. Hydrogel nanoparticle formed by self-assembly of hydrophobized polysaccharide, stabilization of adriamycin by complexation. Eur. J. Pharm. Biopharm. 1996, 42, 286-290.
152. Morimoto, N.; Endo, T.; Iwasaki, Y.; Akiyoshi, K. Design of hybrid hydrogels with self-assembled nanogels as cross-linkers: Interaction with proteins and chaperone-like activity. Biomacromolecules 2005, 6, 1829-1834.
153. Shimoda, A.; Sawada, S. I.; Kano, A.; Maruyama, A.; Moquin, A.; Winnik, F. M.; Akiyoshi, K. Dual crosslinked hydrogel nanoparticles by nanogel bottom-up method for sustained-release delivery. Colloids Surf., B 2012, 99, 38-44.
154. Yang, W. Z.; Chen, H. L.; Gao, F. P.; Chen, M. M.; Li, X. M.; Zhang, M. M.; Zhang, Q. Q.; Liu, L. R.; Jiang, Q.; Wang, Y. S. Selfaggregated Nanoparticles of Cholesterol-modified Pullulan Conjugate as a Novel Carrier of Mitoxantronep. Curr. Nanosci. 2010, 6, 298-306.
155. Na, K.; Lee, E. S.; Bae, Y. H. Self-organized nanogels responding to tumor extracellular pH: pH-dependent drug release and in vitro cytotoxicity against MCF-7 cells. Bioconjugate Chem. 2007, 18, 1568-1574.
156. Seo, S.; Lee, C. S.; Jung, Y. S.; Na, K. Thermo-sensitivity and triggered drug release of polysaccharide nanogels derived from pullulan-g-poly(L-lactide) copolymers. Carbohydr. Polym. 2012, 87, 1105-1111.
157. Sasaki, Y.; Tsuchido, Y.; Sawada, S.; Akiyoshi, K. Construction of protein-crosslinked nanogels with vitamin B-6 bearing polysaccharide. Polym. Chem. 2011, 2, 1267-1270.
158. Na, K.; Lee, K. H.; Bae, Y. H. pH-sensitivity and pH-dependent interior structural change of self-assembled hydrogel nanoparticles of pullulan acetate/oligo-sulfonamide conjugate. J. Controlled Release 2004, 97, 513-525.
159. Okamoto, T.; Saito, T.; Tabata, Y.; Uemoto, S. Immunological tolerance in a mouse model of immune-mediated liver injury induced by 16,16 dimethyl PGE2 and PGE2-containing nanoscale hydrogels. Biomaterials 2011, 32, 4925-4935.
160. Morimoto, N.; Winnik, F. M.; Akiyoshi, K. Botryoidal assembly of cholesteryl-pullulan/poly(N-isopropylacrylamide) nanogels. Langmuir 2007, 23, 217-223.
161. Kim, S.; Park, K. M.; Ko, J. Y.; Kwon, I. C.; Cho, H. G.; Kang, D.; Yu, I. T.; Kim, K.; Na, K. Minimalism in fabrication of selforganized nanogels holding both anti-cancer drug and targeting moiety. Colloids Surf., B 2008, 63, 55-63.
162. Scomparin, A.; Salmaso, S.; Bersani, S.; Satchi-Fainaro, R.; Caliceti, P. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery. Eur. J. Pharm. Sci. 2011, 42, 547-558.
163. Shimoda, A.; Sawada, S.; Akiyoshi, K. Cell Specific Peptide- Conjugated Polysaccharide Nanogels for Protein Delivery. Macromol. Biosci. 2011, 11, 882-888.
164. Taniguchi, I.; Akiyoshi, K.; Sunamoto, J. Self-aggregate nanoparticles of cholesteryl and galactoside groups-substituted pullulan and their specific binding to galactose specific lectin, RCA(120). Macromol. Chem. Phys. 1999, 200, 1554-1560.
165. Hirakura, T.; Yasugi, K.; Nemoto, T.; Sato, M.; Shimoboji, T.; Aso, Y.; Morimoto, N.; Akiyoshi, K. Hybrid hyaluronan hydrogel encapsulating nanogel as a protein nanocarrier: New system for sustained delivery of protein with a chaperone-like function. J. Controlled Release 2010, 142, 483-489.
166. Hayashi, C.; Hasegawa, U.; Saita, Y.; Hemmi, H.; Hayata, T.; Nakashima, K.; Ezura, Y.; Amagasa, T.; Akiyoshi, K.; Noda, M. Osteoblastic Bone Formation Is Induced by Using Nanogel-Crosslinking Hydrogel as Novel Scaffold for Bone Growth Factor. J. Cell. Physiol. 2009, 220, 1-7.
167. Mehvar, R. Dextrans for targeted and sustained delivery of therapeutic and imaging agents. J. Controlled Release 2000, 69, 1-25.
168. Wang, Z. H.; Zhu, Y.; Chai, M. Y.; Yang, W. T.; Xu, F. J. Biocleavable comb-shaped gene carriers from dextran backbones with bioreducible ATRP initiation sites. Biomaterials 2012, 33, 1873-1883.
169. Raemdonck, K.; Naeye, B.; Hogset, H.; Demeester, J.; De Smedt, S. C. Biodegradable dextran nanogels as functional carriers for the intracellular delivery of small interfering RNA. J. Controlled Release 2010, 148, E95-E96.
170. Raemdonck, K.; Naeye, B.; Buyens, K.; Vandenbroucke, R. E.; Hogset, A.; Demeester, J.; De Smedt, S. C. Biodegradable Dextran Nanogels for RNA Interference: Focusing on Endosomal Escape and Intracellular siRNA Delivery. Adv. Funct. Mater. 2009, 19, 1406-1415.
171. Takeo, M.; Mori, T.; Niidome, T.; Sawada, S.; Akiyoshi, K.; Katayama, Y. A polyion complex nanogel. J. Colloid Interface Sci. 2013, 390, 78-84.
172. Peng, K.; Cui, C.; Tomatsu, I.; Porta, F.; Meijer, A. H.; Spaink, H. P.; Kros, A. Cyclodextrin/dextran based drug carriers for a controlled release of hydrophobic drugs in zebrafish embryos. Soft Matter 2010, 6, 3778-3783.
173. Van Thienen, T. G.; Raemdonck, K.; Demeester, J.; De Smedt, S. C. Protein release from biodegradable dextran nanogels. Langmuir 2007, 23, 9794-9801.
174. Klinger, D.; Aschenbrenner, E. M.; Weiss, C. K.; Landfester, K. Enzymatically degradable nanogels by inverse miniemulsion copolymerization of acrylamide with dextran methacrylates as crosslinkers. Polym. Chem. 2012, 3, 204-216.
175. Raemdonck, K.; Naeye, B.; Hogset, A.; Demeester, J.; De Smedt, S. C. Prolonged gene silencing by combining siRNA nanogels and photochemical internalization. J. Controlled Release 2010, 145, 281-288.
176. Van Thienen, T. G.; Lucas, B.; Flesch, F. M.; van Nostrum, C. F.; Demeester, J.; De Smedt, S. C. On the synthesis and characterization of biodegradable dextran nanogels with tunable degradation properties. Macromolecules 2005, 38, 8503-8511.
177. Raemdonck, K.; Demeester, J.; De Smedt, S. Advanced nanogel engineering for drug delivery. Soft Matter 2009, 5, 707-715.
178. Naeye, B.; Raemdonck, K.; Demeester, J.; De Smedt, S. C. Interactions of siRNA loaded dextran nanogel with blood cells. J. Controlled Release 2010, 148, E90-E91.
179. Naeye, B.; Raemdonck, K.; Remaut, K.; Sproat, B.; Demeester, J.; De Smedt, S. C. PEGylation of biodegradable dextran nanogels for siRNA delivery. Eur. J. Pharm. Sci. 2010, 40, 342-351.
180. Naeye, B.; Deschout, H.; Roding, M.; Rudemo, M.; Delanghe, J.; Devreese, K.; Demeester, J.; Braeckmans, K.; De Smedt, S. C.; Raemdonck, K. Hemocompatibility of siRNA loaded dextran nanogels. Biomaterials 2011, 32, 9120-9127.
181. Lv, W. P.; Liu, S. Q.; Feng, W. Q.; Qi, J. J.; Zhang, G. L.; Zhang, F. B.; Fan, X. B. Temperature- and Redox-Directed Multiple Self Assembly of Poly(N-Isopropylacrylamide) Grafted Dextran Nanogels. Macromol. Rapid Commun. 2011, 32, 1101-1107.
182. Wu, Z. M.; Zhang, X. G.; Guo, H. L.; Li, C. X.; Yu, D. M. An injectable and glucose-sensitive nanogel for controlled insulin release. J. Mater. Chem. 2012, 22, 22788-22796.
183. Patnaik, S.; Sharma, A. K.; Garg, B. S.; Gandhi, R. P.; Gupta, K. C. Photoregulation of drug release in azo-dextran nanogels. Int. J. Pharm. 2007, 342, 184-193.
184. Oh, E. J.; Park, K.; Kim, K. S.; Kim, J.; Yang, J. A.; Kong, J. H.; Lee, M. Y.; Hoffman, A. S.; Hahn, S. K. Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. J. Controlled Release 2010, 141, 2-12.
185. Lokeshwar, V. B.; Selzer, M. G. Differences in hyaluronic acidmediated functions and signaling in arterial, microvessel, and veinderived human endothelial cells. J. Biol. Chem. 2000, 275, 27641-27649.
186. Price, R. D.; Myers, S.; Leigh, I. M.; Navsaria, H. A. The role of hyaluronic acid in wound healing - Assessment of clinical evidence. Am. J. Clin. Dermatol. 2005, 6, 393-402.
187. Rosines, E.; Schmidt, H. J.; Nigam, S. K. The effect of hyaluronic acid size and concentration on branching morphogenesis and tubule differentiation in developing kidney culture systems: Potential applications to engineering of renal tissues. Biomaterials 2007, 28, 4806-4817.
188. Toh, W. S.; Lim, T. C.; Kurisawa, M.; Spector, M. Modulation of mesenchymal stem cell chondrogenesis in a tunable hyaluronic acid hydrogel microenvironment. Biomaterials 2012, 33, 3835-3845.
189. Park, W.; Kim, K. S.; Bae, B. C.; Kim, Y. H.; Na, K. Cancer cell specific targeting of nanogels from acetylated hyaluronic acid with low molecular weight. Eur. J. Pharm. Sci. 2010, 40, 367-375.
190. Li, J.; Huo, M. R.; Wang, J.; Zhou, J. P.; Mohammad, J. M.; Zhang, Y. L.; Zhu, Q. N.; Waddad, A. Y.; Zhang, Q. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. Biomaterials 2012, 33, 2310-2320.
191. Lee, H.; Mok, H.; Lee, S.; Oh, Y. K.; Park, T. G. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J. Controlled Release 2007, 119, 245-252.
192. Nakai, T.; Hirakura, T.; Sakurai, Y.; Shimoboji, T.; Ishigai, M.; Akiyoshi, K. Injectable Hydrogel for Sustained Protein Release by Salt- Induced Association of Hyaluronic Acid Nanogel. Macromol. Biosci. 2012, 12, 475-483.
193. Oyarzun-Ampuero, F. A.; Goycoolea, F. M.; Torres, D.; Alonso, M. J. A new drug nanocarrier consisting of polyarginine and hyaluronic acid. Eur. J. Pharm. Biopharm. 2011, 79, 54-57.
194. He, Y.; Cheng, G.; Xie, L.; Nie, Y.; He, B.; Gu, Z. Polyethyleneimine/DNA polyplexes with reduction-sensitive hyaluronic acid derivatives shielding for targeted gene delivery. Biomaterials 2013, 34, 1235-1245.
195. Cho, H. J.; Yoon, H. Y.; Koo, H.; Ko, S. H.; Shim, J. S.; Lee, J. H.; Kim, K.; Chan Kwon, I.; Kim, D. D. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic (R) for tumor-targeted delivery of docetaxel. Biomaterials 2011, 32, 7181-7190.
196. Saravanakumar, G.; Choi, K. Y.; Yoon, H. Y.; Kim, K.; Park, J. H.; Kwon, I. C.; Park, K. Hydrotropic hyaluronic acid conjugates: Synthesis, characterization, and implications as a carrier of paclitaxel. Int. J. Pharm. 2010, 394, 154-161.
197. Choi, K. Y.; Min, K. H.; Na, J. H.; Choi, K.; Kim, K.; Park, J. H.; Kwon, I. C.; Jeong, S. Y. Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: synthesis, characterization, and in vivo biodistribution. J. Mater. Chem. 2009, 19, 4102-4107.
198. Choi, K. Y.; Min, K. H.; Yoon, H. Y.; Kim, K.; Park, J. H.; Kwon, I. C.; Choi, K.; Jeong, S. Y. PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo. Biomaterials 2011, 32, 1880-1889.
199. Cho, H. J.; Yoon, I. S.; Yoon, H. Y.; Koo, H.; Jin, Y. J.; Ko, S. H.; Shim, J. S.; Kim, K.; Kwon, I. C.; Kim, D. D. Polyethylene glycolconjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin. Biomaterials 2012, 33, 1190-1200.
200. Ndungu, J. M.; Lu, Y. J.; Zhu, S. J.; Yang, C.; Wang, X.; Chen, G.; Shin, D. M.; Snyder, J. P.; Shoji, M.; Sun, A. M. Targeted Delivery of Paclitaxel to Tumor Cells: Synthesis and in Vitro Evaluation. J. Med. Chem. 2010, 53, 3127-3132.
201. Goncalves, A.; Braguer, D.; Kamath, K.; Martello, L.; Briand, C.; Horwitz, S.; Wilson, L.; Jordan, M. A. Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics. Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 11737-11742.
202. del Burgo, L. S.; Hernandez, R. M.; Orive, G.; Pedraz, J. L. Nanotherapeutic approaches for brain cancer management. Nanomedicine 2014, 10, 905-919.
203. Jiang, G.; Wei, Z. P.; Pei, D. S.; Xin, Y.; Liu, Y. Q.; Zheng, J. N. A novel approach to overcome Temozolomide resistance in glioma and melanoma: Inactivation of MGMT by gene therapy. Biochem. Biophys. Res. Commun. 2011, 406, 311-314.
204. Wu, W. T.; Shen, J.; Banerjee, P.; Zhou, S. Q. Core-shell hybrid nanogels for integration of optical temperature-sensing, targeted tumor cell imaging, and combined chemo-photothermal treatment. Biomaterials 2010, 31, 7555-7566.
205. George, M.; Abraham, T. E. Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan - a review. J. Controlled Release 2006, 114, 1-14.
206. Chan, A. W.; Neufeld, R. J. Tuneable semi-synthetic network alginate for absorptive encapsulation and controlled release of protein therapeutics. Biomaterials 2010, 31, 9040-9047.
207. Kolambkar, Y. M.; Dupont, K. M.; Boerckel, J. D.; Huebsch, N.; Mooney, D. J.; Hutmacher, D. W.; Guldberg, R. E. An alginatebased hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials 2011, 32, 65-74.
208. Varshney, R. R.; Zhou, R. J.; Hao, J. H.; Yeo, S. S.; Chooi, W. H.; Fan, J. B.; Wang, D. A. Chondrogenesis of synovium-derived mesenchymal stem cells in gene-transferred co-culture system. Biomaterials 2010, 31, 6876-6891.
209. Dong, L.; Xia, S. H.; Wu, K.; Huang, Z.; Chen, H. A.; Chen, J. N.; Zhang, J. F. A pH/Enzyme-responsive tumor-specific delivery system for doxorubicin. Biomaterials 2010, 31, 6309-6316.
210. Hunt, N. C.; Shelton, R. M.; Grover, L. M. Reversible mitotic and metabolic inhibition following the encapsulation of fibroblasts in alginate hydrogels. Biomaterials 2009, 30, 6435-6443.
211. Hwang, Y. S.; Cho, J.; Tay, F.; Heng, J. Y. Y.; Ho, R.; Kazarian, S. G.; Williams, D. R.; Boccaccini, A. R.; Polak, J. M.; Mantalaris, A. The use of murine embryonic stem cells, alginate encapsulation, and rotary microgravity bioreactor in bone tissue engineering. Biomaterials 2009, 30, 499-507.
212. Rajaonarivony, M.; Vauthier, C.; Couarraze, G.; Puisieux, F.; Couvreur, P. Development of a New Drug Carrier Made from Alginate. J. Pharm. Sci. 1993, 82, 912-917.
213. Parveen, S.; Mitra, M.; Krishnakumar, S.; Sahoo, S. K. Enhanced antiproliferative activity of carboplatin-loaded chitosan- alginate nanoparticles in a retinoblastoma cell line. Acta Biomater. 2010, 6, 3120-3131.
214. Woitiski, C. B.; Sarmento, B.; Carvalho, R. A.; Neufeld, R. J.; Veiga, F. Facilitated nanoscale delivery of insulin across intestinal membrane models. Int. J. Pharm. 2011, 412, 123-131.
215. Cai, H.; Ni, C. H.; Zhang, L. P. Preparation of complex nanoparticles based on alginic acid/poly[(2-dimethylamino) ethyl methacrylate] and a drug vehicle for doxorubicin release controlled by ionic strength. Eur. J. Pharm. Sci. 2012, 45, 43-49.
216. De, S.; Robinson, D. Polymer relationships during preparation of chitosan-alginate and poly-l-lysine-alginate nanospheres. J. Controlled Release 2003, 89, 101-112.
217. Azizi, E.; Namazi, A.; Haririan, I.; Fouladdel, S.; Khoshayand, M. R.; Shotorbani, P. Y.; Nomani, A.; Gazori, T. Release profile and stability evaluation of optimized chitosan/alginate nanoparticles as EGFR antisense vector. Int. J. Nanomed. 2010, 5, 455-461.
218. Ahmad, Z.; Sharma, S.; Khuller, G. K. Chemotherapeutic evaluation of alginate nanoparticle-encapsulated azole antifungal and antitubercular drugs against murine tuberculosis. Nanomedicine 2007, 3, 239-243.
219. Nanjwade, B. K.; Singh, J.; Parikh, K. A.; Manvi, F. V. Preparation and evaluation of carboplatin biodegradable polymeric nanoparticles. Int. J. Pharm. 2010, 385, 176-180.
220. Sarmento, B.; Ferreira, D.; Veiga, F.; Ribeiro, A. Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies. Carbohydr. Polym. 2006, 66, 1-7.
221. Gazori, T.; Khoshayand, M. R.; Azizi, E.; Yazdizade, P.; Nomani, A.; Haririan, I. Evaluation of Alginate/Chitosan nanoparticles as antisense delivery vector: Formulation, optimization and in vitro characterization. Carbohydr. Polym. 2009, 77, 599-606.
222. Gazori, T.; Haririan, I.; Fouladdel, S.; Namazi, A.; Nomani, A.; Azizi, E. Inhibition of EGFR expression with chitosan/alginate nanoparticles encapsulating antisense oligonucleotides in T47D cell line using RT-PCR and immunocytochemistry. Carbohydr. Polym. 2010, 80, 1042-1047.
223. Jung, T.; Kamm, W.; Breitenbach, A.; Kaiserling, E.; Xiao, J. X.; Kissel, T. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur. J. Pharm. Biopharm. 2000, 50, 147-160.
224. Zhang, N.; Li, J. H.; Jiang, W. F.; Ren, C. H.; Li, J. S.; Xin, J. Y.; Li, K. Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles. Int. J. Pharm. 2010, 393, 213-219.
225. Woitiski, C. B.; Veiga, F.; Ribeiro, A.; Neufeld, R. Design for optimization of nanoparticles integrating biomaterials for orally dosed insulin. Eur. J. Pharm. Biopharm. 2009, 73, 25-33.
226. Martinez, A.; Iglesias, I.; Lozano, R.; Teijon, J. M.; Blanco, M. D.; Controlled, G. P. M. Synthesis and characterization of thiolated alginate-albumin nanoparticles stabilized by disulfide bonds. Evaluation as drug delivery systems. Carbohydr. Polym. 2011, 83, 1311-1321.
227. Martinez, A.; Benito-Miguel, M.; Iglesias, I.; Teijon, J. M.; Blanco, M. D. Tamoxifen-loaded thiolated alginate-albumin nanoparticles as antitumoral drug delivery systems. J. Biomed. Mater. Res., Part A 2012, 100A, 1467-1476.
228. Martinez, A.; Muniz, E.; Iglesias, I.; Teijon, J. M.; Blanco, M. D. Enhanced preclinical efficacy of tamoxifen developed as alginatecysteine/ disulfide bond reduced albumin nanoparticles. Int. J. Pharm. 2012, 436, 574-581.
229. Sieuwerts, A. M.; Lyng, M. B.; Meijer-van Gelder, M. E.; de Weerd, V.; Sweep, F. C. G. J.; Foekens, J. A.; Span, P. N.; Martens, J. W. M.; Ditzel, H. J. Evaluation of the ability of adjuvant tamoxifenbenefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting. Mol. Oncol. 2014, 8, 1679-1689.
230. Kratz, F. Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles. J. Controlled Release 2008, 132, 171-183.
231. Huang, W.; Wang, W.; Wang, P.; Tian, Q.; Zhang, C. N.; Wang, C. H.; Yuan, Z.; Liu, M.; Wan, H. Y.; Tang, H. Glycyrrhetinic acid-modified poly(ethylene glycol)-b-poly(gamma-benzyl L-glutamate) micelles for liver targeting therapy. Acta Biomater. 2010, 6, 3927-3935.
232. Zhang, C. N.; Wang, W.; Liu, T.; Wu, Y. K.; Guo, H.; Wang, P.; Tian, Q.; Wang, Y. M.; Yuan, Z. Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy. Biomaterials 2012, 33, 2187-2196.
233. Anderson, E.; Pierre-Louis, W. S.; Wong, C. J.; Lary, J. W.; Cole, J. L. Heparin Activates PKR by Inducing Dimerization. J. Mol. Biol. 2011, 413, 973-984.
234. Dreyfuss, J. L.; Regatieri, C. V.; Jarrouge, T. R.; Cavalheiro, R. P.; Sampaio, L. O.; Nader, H. B. Heparan sulfate proteoglycans: structure, protein interactions and cell signaling. An. Acad. Bras. Cienc. 2009, 81, 409-429.
235. Sasisekharan, R.; Shriver, Z.; Venkataraman, G.; Narayanasami, U. Roles of heparan-sulphate glycosaminoglycans in cancer. Nat. Rev. Cancer 2002, 2, 521-528.
236. Niers, T. M. H.; Klerk, C. P. W.; DiNisio, M.; Van Noorden, C. J. F.; Buller, H. R.; Reitsma, P. H.; Richel, D. J. Mechanisms of heparin induced anti-cancer activity in experimental cancer models. Crit. Rev. Oncol. Hemat. 2007, 61, 195-207.
237. Choi, J. H.; Jang, J. Y.; Joung, Y. K.; Kwon, M. H.; Park, K. D. Intracellular delivery and anti-cancer effect of self-assembled heparin- Pluronic nanogels with RNase A. J. Controlled Release 2010, 147, 420-427.
238. Choi, J. H.; Joung, Y. K.; Bae, J. W.; Choi, J. W.; Quyen, T. N.; Park, K. D. Self-Assembled Nanogel of Pluronic-Conjugated Heparin as a Versatile Drug Nanocarrier. Macromol. Res. 2011, 19, 180-188.
239. Li, L.; Bae, B. C.; Tran, T. H.; Yoon, K. H.; Na, K.; Huh, K. M. Self-quenchable biofunctional nanoparticles of heparin-folate-photosensitizer conjugates for photodynamic therapy. Carbohydr. Polym. 2011, 86, 708-715.
240. Yang, F.; Gou, M. L.; Deng, H. X.; Yi, T.; Zhong, Q.; Wei, Y. Q.; Zhao, X. Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels. Oncol. Rep. 2012, 28, 668-676.
241. Liu, P.; Gou, M. L.; Yi, T.; Xie, C.; Qi, X. R.; Zhou, S. T.; Deng, H. X.; Wei, Y. Q.; Zhao, X. Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels. Oncol. Rep. 2012, 27, 363-370.
242. Liu, P.; Gou, M. L.; Yi, T.; Qi, X. R.; Xie, C.; Zhou, S. T.; Deng, H. X.; Wei, Y. Q.; Zhao, X. The enhanced antitumor effects of biodegradable cationic heparin-polyethyleneimine nanogels delivering HSulf-1 gene combined with cisplatin on ovarian cancer. Int. J. Oncol. 2012, 41, 1504-1512.
243. Zhang, Y. N.; Wang, X.; Qiu, Y. W.; Cornish, J.; Carr, A. J.; Xia, Z. D. Effect of indomethacin and lactoferrin on human tenocyte proliferation and collagen formation in vitro. Biochem. Biophys. Res. Commun. 2014, 454, 301-307.
244. Lee, J. H.; Lee, H.; Joung, Y. K.; Jung, K. H.; Choi, J. H.; Lee, D. H.; Park, K. D.; Hong, S. S. The use of low molecular weight heparin-pluronic nanogels to impede liver fibrosis by inhibition the TGF-beta/Smad signaling pathway. Biomaterials 2011, 32, 1438-1445.
245. Wei, W.; Mu, Y. D.; Li, X. P.; Gou, M. L.; Zhang, H. L.; Luo, S. T.; Men, K.; Mao, Y. Q.; Qian, Z. Y.; Yang, L. Adenoviral Vectors Modified by Heparin-Polyethyleneimine Nanogels Enhance Targeting to the Lung and Show Therapeutic Potential for Pulmonary Metastasis In Vivo. J. Biomed. Nanotechnol. 2011, 7, 768-775.
246. Bae, K. H.; Mok, H.; Park, T. G. Synthesis, characterization, and intracellular delivery of reducible heparin nanogels for apoptotic cell death. Biomaterials 2008, 29, 3376-3383.
247. Nguyen, D. H.; Joung, Y. K.; Choi, J. H.; Moon, H. T.; Park, K. D. Targeting ligand-functionalized and redox-sensitive heparin- Pluronic nanogels for intracellular protein delivery. Biomed. Mater. 2011, 6, 55004-55013.
248. Shinde, U. A.; Nagarsenker, M. S. Characterization of Gelatin- Sodium Alginate Complex Coacervation System. Indian J. Pharm. Sci. 2009, 71, 313-317.
249. Lee, K. Y.; Mooney, D. J. Hydrogels for tissue engineering. Chem. Rev. 2001, 101, 1869-1879.
250. Layman, H.; Spiga, M. G.; Brooks, T.; Pham, S.; Webster, K. A.; Andreopoulos, F. M. The effect of the controlled release of basic fibroblast growth factor from ionic gelatin-based hydrogels on angiogenesis in a murine critical limb ischemic model. Biomaterials 2007, 28, 2646-2654.
251. Chen, F. M.; Zhao, Y. M.; Sun, H. H.; Jin, T.; Wang, Q. T.; Zhou, W.; Wu, Z. F.; Jin, Y. Novel glycidyl methacrylated dextran (Dex-GMA)/gelatin hydrogel scaffolds containing microspheres loaded with bone morphogenetic proteins: Formulation and characteristics. J. Controlled Release 2007, 118, 65-77.
252. Hwang, J. H.; Kim, I. G.; Lee, J. Y.; Piao, S.; Lee, D. S.; Lee, T. S.; Ra, J. C.; Lee, J. Y. Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel. Biomaterials 2011, 32, 4415-4423.
253. Yadav, S. C.; Kumari, A.; Yadav, R. Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation. Peptides 2011, 32, 173-187.
254. Akiyama, Y.; Fujiwara, T.; Takeda, S. I.; Izumi, Y.; Nishijima, S. Preparation of stimuli-responsive protein nanogel by quantum-ray irradiation. Colloid Polym. Sci. 2007, 285, 801-807.
255. Gan, Z. H.; Ju, J. H.; Zhang, T.; Wu, D. C. Preparation of Rhodamine B Fluorescent Poly(methacrylic acid) Coated Gelatin Nanoparticles. J. Nanomater. 2011, 2011, 1-8.
256. Koul, V.; Mohamed, R.; Kuckling, D.; Adler, H. J. P.; Choudhary, V. Interpenetrating polymer network (IPN) nanogels based on gelatin and poly(acrylic acid) by inverse miniemulsion technique: Synthesis and characterization. Colloids Surf., B 2011, 83, 204-213.
257. Park, W.; Park, S. J.; Na, K. Potential of self-organizing nanogel with acetylated chondroitin sulfate as an anti-cancer drug carrier. Colloids Surf., B 2010, 79, 501-508.
258. Toita, S.; Soma, Y.; Morimoto, N.; Akiyoshi, K. Cycloamylosebased Biomaterial: Nanogel of Cholesterol-bearing Cationic Cycloamylose for siRNA Delivery. Chem. Lett. 2009, 38, 1114-1115.
259. Cao, Y.; Gu, Y.; Ma, H.; Bai, J.; Liu, L. N.; Zhao, P. G.; He, H. X. Self-assembled nanoparticle drug delivery systems from galactosylated polysaccharide-doxorubicin conjugate loaded doxorubicin. Int. J. Biol. Macromol. 2010, 46, 245-249.
260. Na, K.; Park, K. H.; Kim, S. W.; Bae, Y. H. Self-assembled hydrogel nanoparticles from Curdlan derivatives: characterization, anti-cancer drug release and interaction with a hepatoma cell line (HepG2). J. Controlled Release 2000, 69, 225-236.
261. Wu, W. T.; Aiello, M.; Zhou, T.; Berliner, A.; Banerjee, P.; Zhou, S. Q. In-situ immobilization of quantum dots in polysaccharidebased nanogels for integration of optical pH-sensing, tumor cell imaging, and drug delivery. Biomaterials 2010, 31, 3023-3031.
262. Carvalho, V.; Castanheira, P.; Madureira, P.; Ferreira, S. A.; Costa, C.; Teixeira, J. P.; Faro, C.; Vilanova, M.; Gama, M. Self- Assembled Dextrin Nanogel as Protein Carrier: Controlled Release and Biological Activity of IL-10. Biotechnol. Bioeng. 2011, 108, 1977- 1986.
263. Wang, D. A.; Varghese, S.; Sharma, B.; Strehin, I.; Fermanian, S.; Gorham, J.; Fairbrother, D. H.; Cascio, B.; Elisseeff, J. H. Multifunctional chondroitin sulphate for cartilage tissue-biomaterial integration. Nat. Mater. 2007, 6, 385-392.
264. Li, F. Y.; Na, K. Self-Assembled Chlorin e6 Conjugated Chondroitin Sulfate Nanodrug for Photodynamic Therapy. Biomacromolecules 2011, 12, 1724-1730.
265. Xi, J.; Zhou, L.; Dai, H. Drug-loaded chondroitin sulfate-based nanogels: Preparation and characterization. Colloids Surf., B 2012, 100, 107-115.
266. Toita, S.; Morimoto, N.; Akiyoshi, K. Functional Cycloamylose as a Polysaccharide-Based Biomaterial: Application in a Gene Delivery System. Biomacromolecules 2010, 11, 397-401.
267. Chen, D. D.; Guo, P.; Chen, S.; Cao, Y.; Ji, W. Z.; Lei, X.; Liu, L. N.; Zhao, P. G.; Wang, R. H.; Qi, C.; Liu, Y. L.; He, H. X. Properties of xyloglucan hydrogel as the biomedical sustained-release carriers. J. Mater. Sci.: Mater. Med. 2012, 23, 955-962.
268. Hreczuk-Hirst, D.; Chicco, D.; German, L.; Duncan, R. Dextrins as potential carriers for drug targeting: tailored rates of dextrin degradation by introduction of pendant groups. Int. J. Pharm. 2001, 230, 57-66.
269. Goncalves, C.; Martins, J. A.; Gama, F. M. Self-assembled nanoparticles of dextrin substituted with hexadecanethiol. Biomacromolecules 2007, 8, 392-398.
270. Haddad, J. J.; Fahlman, C. S. Redox- and oxidant-mediated regulation of interleukin-10: an anti-inflammatory, antioxidant cytokine? Biochem. Biophys. Res. Commun. 2002, 297, 163-176.
271. Carvalho, V.; Castanheira, P.; Faria, T. Q.; Goncalves, C.; Madureira, P.; Faro, C.; Domingues, L.; Brito, R. M. M.; Vilanova, M.; Gama, M. Biological activity of heterologous murine interleukin-10 and preliminary studies on the use of a dextrin nanogel as a delivery system. Int. J. Pharm. 2010, 400, 234-242.
272. Drury, J. L.; Mooney, D. J. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 2003, 24, 4337-4351.
273. Ding, J. X.; Zhuang, X. L.; Xiao, C. S.; Cheng, Y. L.; Zhao, L.; He, C. L.; Tang, Z. H.; Chen, X. S. Preparation of photo-cross-linked pH-responsive polypeptide nanogels as potential carriers for controlled drug delivery. J. Mater. Chem. 2011, 21, 11383-11391.
274. Ding, J. X.; Shi, F. H.; Xiao, C. S.; Lin, L.; Chen, L.; He, C. L.; Zhuang, X. L.; Chen, X. S. One-step preparation of reductionresponsive poly(ethylene glycol)-poly (amino acid)s nanogels as efficient intracellular drug delivery platforms. Polym. Chem. 2011, 2, 2857-2864.
275. Xing, T.; Lai, B.; Ye, X. D.; Yan, L. F. Disulfide Core Cross- Linked PEGylated Polypeptide Nanogel Prepared by a One-Step Ring Opening Copolymerization of N-Carboxyanhydrides for Drug Delivery. Macromol. Biosci. 2011, 11, 962-969.
276. Chung, H. J.; Park, T. G. Self-assembled and nanostructured hydrogels for drug delivery and tissue engineering. Nano Today 2009, 4, 429-437.
277. Oh, N. M.; Kwag, D. S.; Oh, K. T.; Youn, Y. S.; Lee, E. S. Electrostatic charge conversion processes in engineered tumoridentifying polypeptides for targeted chemotherapy. Biomaterials 2012, 33, 1884-1893.
278. Thambi, T.; Yoon, H. Y.; Kim, K.; Kwon, I. C.; Yoo, C. K.; Park, J. H. Bioreducible Block Copolymers Based on Poly(Ethylene Glycol) and Poly(gamma-Benzyl L-Glutamate) for Intracellular Delivery of Camptothecin. Bioconjugate Chem. 2011, 22, 1924-1931.
279. Oh, N. M.; Oh, K. T.; Youn, Y. S.; Lee, D. K.; Cha, K. H.; Lee, D. H.; Lee, E. S. Poly(L-aspartic acid) nanogels for lysosome-selective antitumor drug delivery. Colloids Surf., B 2013, 101, 298-306.
280. Shi, F. H.; Ding, J. X.; Xiao, C. S.; Zhuang, X. L.; He, C. L.; Chen, L.; Chen, X. S. Intracellular microenvironment responsive PEGylated polypeptide nanogels with ionizable cores for efficient doxorubicin loading and triggered release. J. Mater. Chem. 2012, 22, 14168-14179.
281. Nagahama, K.; Hashizume, M.; Yamamoto, H.; Ouchi, T.; Ohya, Y. Hydrophobically Modified Biodegradable Poly(ethylene glycol) Copolymers that Form Temperature-Responsive Nanogels. Langmuir 2009, 25, 9734-9740.
282. Lapienis, G. Star-shaped polymers having PEO arms. Prog. Polym. Sci. 2009, 34, 852-892.
283. Larson, T. A.; Joshi, P. R.; Sokolov, K. Preventing Protein Adsorption and Macrophage Uptake of Gold Nanoparticles via a Hydrophobic Shield. ACS Nano 2012, 6, 9182-9190.
284. Oh, J. K.; Siegwart, D. J.; Lee, H. I.; Sherwood, G.; Peteanu, L.; Hollinger, J. O.; Kataoka, K.; Matyjaszewski, K. Biodegradable nanogels prepared by atom transfer radical polymerization as potential drug delivery carriers: Synthesis, biodegradation, in vitro release, and bioconjugation. J. Am. Chem. Soc. 2007, 129, 5939-5945.
285. Qiao, Z. Y.; Zhang, R.; Du, F. S.; Liang, D. H.; Li, Z. C. Multiresponsive nanogels containing motifs of ortho ester, oligo(ethylene glycol) and disulfide linkage as carriers of hydrophobic anti-cancer drugs. J. Controlled Release 2011, 152, 57-66.
286. Lee, W. C.; Li, Y. C.; Chu, I. M. Amphiphilic poly(D,L-lactic acid)/poly(ethylene glycol)/poly(D,L-lactic acid) nanogels for controlled release of hydrophobic drugs. Macromol. Biosci. 2006, 6, 846-854.
287. Mok, H.; Park, T. G. PEG-assisted DNA solubilization in organic solvents for preparing cytosol specifically degradable PEG/ DNA nanogels. Bioconjugate Chem. 2006, 17, 1369-1372.
288. Abdullah-Al-Nahain; Lee, H.; Lee, Y. S.; Lee, K. D.; Park, S. Y. Development of Disulfide Core-Crosslinked Pluronic Nanoparticles as an Effective Anticancer-Drug-Delivery System. Macromol. Biosci. 2011, 11, 1264-1271.
289. Ryu, J. H.; Chacko, R. T.; Jiwpanich, S.; Bickerton, S.; Babu, R. P.; Thayumanavan, S. Self-Cross-Linked Polymer Nanogels: A Versatile Nanoscopic Drug Delivery Platform. J. Am. Chem. Soc. 2010, 132, 17227-17235.
290. Groll, J.; Singh, S.; Albrecht, K.; Moeller, M. Biocompatible and Degradable Nanogels via Oxidation Reactions of Synthetic Thiomers in Inverse Miniemulsion. J. Polym. Sci., Part A: Polym. Chem. 2009, 47, 5543-5549.
291. Oh, J. K.; Tang, C. B.; Gao, H. F.; Tsarevsky, N. V.; Matyjaszewski, K. Inverse miniemulsion ATRP: A new method for synthesis and functionalization of well-defined water-soluble/crosslinked polymeric particles. J. Am. Chem. Soc. 2006, 128, 5578-5584.
292. Oh, J. K.; Siegwart, D. J.; Matyjaszewski, K. Synthesis and biodegradation of nanogels as delivery carriers for carbohydrate drugs. Biomacromolecules 2007, 8, 3326-3331.
293. Lee, Y.; Park, S. Y.; Kim, C.; Park, T. G. Thermally triggered intracellular explosion of volume transition nanogels for necrotic cell death. J. Controlled Release 2009, 135, 89-95.
294. Wu, J.; Liu, X. Q.; Wang, Y. C.; Wang, J. Template-free synthesis of biodegradable nanogels with tunable sizes as potential carriers for drug delivery. J. Mater. Chem. 2009, 19, 7856-7863.
295. Medina, S. H.; El-Sayed, M. E. H. Dendrimers as Carriers for Delivery of Chemotherapeutic Agents. Chem. Rev. 2009, 109, 3141-3157.
296. Steinhilber, D.; Sisson, A. L.; Mangoldt, D.; Welker, P.; Licha, K.; Haag, R. Synthesis, Reductive Cleavage, and Cellular Interaction Studies of Biodegradable, Polyglycerol Nanogels. Adv. Funct. Mater. 2010, 20, 4133-4138.
297. Sisson, A. L.; Haag, R. Polyglycerol nanogels: highly functional scaffolds for biomedical applications. Soft Matter 2010, 6, 4968-4975.
298. Cuggino, J. C.; Alvarez, C. I.; Strumia, M. C.; Welker, P.; Licha, K.; Steinhilber, D.; Mutihac, R. C.; Calderon, M. Thermosensitive nanogels based on dendritic polyglycerol and N-isopropylacrylamide for biomedical applications. Soft Matter 2011, 7, 11259-11266.
299. Khandare, J.; Calderon, M.; Dagia, N. M.; Haag, R. Multifunctional dendritic polymers in nanomedicine: opportunities and challenges. Chem. Soc. Rev. 2012, 41, 2824-2848.
300. Zhao, M. X.; Biswas, A.; Hu, B. L.; Joo, K. I.; Wang, P.; Gu, Z.; Tang, Y. Redox-responsive nanocapsules for intracellular protein delivery. Biomaterials 2011, 32, 5223-5230.
301. Treguer, K.; Naye, F.; Thiebaud, P.; Fedou, S.; Soulet, F.; Theze, N.; Faucheux, C. Smooth muscle cell differentiation from human bone marrow: Variations in cell type specific markers and Id gene expression in a new model of cell culture. Cell Biol. Int. 2009, 33, 621-631.
302. Bhuchar, N.; Sunasee, R.; Ishihara, K.; Thundat, T.; Narain, R. Degradable Thermoresponsive Nanogels for Protein Encapsulation and Controlled Release. Bioconjugate Chem. 2012, 23, 75-83.
303. Aliyar, H. A.; Hamilton, P. D.; Remsen, E. E.; Ravi, N. Synthesis of polyacrylamide nanogels by intramolecular disulfide crosslinking. J. Bioact. Compat. Polym. 2005, 20, 169-181.
304. Meng, J. N.; Sturgis, T. F.; Youan, B. B. C. Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion. Eur. J. Pharm. Sci. 2011, 44, 57-67.
305. Li, Y. L.; Maciel, D.; Tomás, H.; Rodrigues, J.; Ma, H.; Shi, X. Y. pH sensitive Laponite/alginate hybrid hydrogels: swelling behaviour and release mechanism. Soft Matter 2011, 7, 6231-6238.
306. Borges, O.; Cordeiro-Da-Silva, A.; Romeijn, S. G.; Amidi, M.; de Sousa, A.; Borchard, G.; Junginger, H. E. Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination. J. Controlled Release 2006, 114, 348-358.
307. Perkin, K. K.; Turner, J. L.; Wooley, K. L.; Mann, S. Fabrication of hybrid nanocapsules by calcium phosphate mineralization of shell cross-linked polymer micelles and nanocages. Nano Lett. 2005, 5, 1457-1461.
308. Lee, H. J.; Kim, S. E.; Kwon, I. K.; Park, C.; Kim, C.; Yang, J.; Lee, S. C. Spatially mineralized self-assembled polymeric nanocarriers with enhanced robustness and controlled drug-releasing property. Chem. Commun. 2010, 46, 377-379.
309. Han, S. Y.; Han, H. S.; Lee, S. C.; Kang, Y. M.; Kim, I. S.; Park, J. H. Mineralized hyaluronic acid nanoparticles as a robust drug carrier. J. Mater. Chem. 2011, 21, 7996-8001.
310. Jain, A.; Gupta, Y.; Jain, S. K. Perspectives of biodegradable natural polysaccharides for site-specific drug delivery to the colon. J. Pharm. Pharm. Sci. 2007, 10, 86-128.
311. Vu, T. H.; Werb, Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 2000, 14, 2123-2133.
312. Regmi, R.; Bhattarai, S. R.; Sudakar, C.; Wani, A. S.; Cunningham, R.; Vaishnava, P. P.; Naik, R.; Oupicky, D.; Lawes, G. Hyperthermia controlled rapid drug release from thermosensitive magnetic microgels. J. Mater. Chem. 2010, 20, 6158-6163.
313. Zhang, J.; Misra, R. D. K. Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: Core-shell nanoparticle carrier and drug release response. Acta Biomater. 2007, 3, 838-850.
314. Yang, K.; Hu, L. L.; Ma, X. X.; Ye, S. Q.; Cheng, L.; Shi, X. Z.; Li, C. H.; Li, Y. G.; Liu, Z. Multimodal Imaging Guided Photothermal Therapy using Functionalized Graphene Nanosheets Anchored with Magnetic Nanoparticles. Adv. Mater. 2012, 24, 1868-1872.
315. Wang, C.; Mallela, J.; Garapati, U. S.; Ravi, S.; Chinnasamy, V.; Girard, Y.; Howell, M.; Mohapatra, S. A chitosan-modified graphene nanogel for noninvasive controlled drug release. Nanomedicine 2013, 9, 903-911.
316. Moore, C. M.; Pendse, D.; Emberton, M. Photodynamic therapy for prostate cancer - a review of current status and future promise. Nat. Clin. Pract. Urol. 2009, 6, 18-30.
317. Yoon, H. Y.; Koo, H.; Choi, K. Y.; Lee, S. J.; Kim, K.; Kwon, I. C.; Leary, J. F.; Park, K.; Yuk, S. H.; Park, J. H.; Choi, K. Tumortargeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. Biomaterials 2012, 33, 3980-3989.
318. Bae, B. C.; Na, K. Self-quenching polysaccharide-based nanogels of pullulan/folate-photosensitizer conjugates for photodynamic therapy. Biomaterials 2010, 31, 6325-6335.
319. Zhan, F. X.; Chen, W.; Wang, Z. J.; Lu, W. T.; Cheng, R.; Deng, C.; Meng, F. H.; Liu, H. Y.; Zhong, Z. Y. Acid-Activatable Prodrug Nanogels for Efficient Intracellular Doxorubicin Release. Biomacromolecules 2011, 12, 3612-3620.
320. Zhang, H. T.; Li, F.; Yi, J.; Gu, C. H.; Fan, L.; Qiao, Y. B.; Tao, Y. C.; Cheng, C.; Wu, H. Folate-decorated maleilated pullulandoxorubicin conjugate for active tumor-targeted drug delivery. Eur. J. Pharm. Sci. 2011, 42, 517-526.
321. Lee, S. J.; Koo, H.; Jeong, H.; Huh, M. S.; Choi, Y.; Jeong, S. Y.; Byun, Y.; Choi, K.; Kim, K.; Kwon, I. C. Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy. J. Controlled Release 2011, 152, 21-29.
322. Vinogradov, S. V. Polymeric nanogel formulations of nucleoside analogs. Expert Opin. Drug Delivery 2007, 4, 5-17.
323. Luten, J.; van Nostrum, C. F.; De Smedt, S. C.; Hennink, W. E. Biodegradable polymers as non-viral carriers for plasmid DNA delivery. J. Controlled Release 2008, 126, 97-110.
324. Kohli, E.; Han, H. Y.; Zeman, A. D.; Vinogradov, S. V. Formulations of biodegradable Nanogel carriers with 5′-triphosphates of nucleoside analogs that display a reduced cytotoxicity and enhanced drug activity. J. Controlled Release 2007, 121, 19-27.
325. Gosselin, M. A.; Guo, W. J.; Lee, R. J. Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjugate Chem. 2001, 12, 989-994.
326. Vinogradov, S. V.; Li, E. K.; Zeman, A.; Kabanov, A. V. POLY 416-Chemical engineering of nanogel drug carriers: Increased bioavailability and decreased cytotoxicity. Polym. Prepr. 2006, 47, 27-28.
327. Lim, S. B.; Banerjee, A.; Onyuksel, H. Improvement of drug safety by the use of lipid-based nanocarriers. J. Controlled Release 2012, 163, 34-45.
328. Yang, Z.; Leon, J.; Martin, M.; Harder, J. W.; Zhang, R.; Liang, D.; Lu, W.; Tian, M.; Gelovani, J. G.; Qiao, A.; Li, C. Pharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles. Nanotechnology 2009, 20, 165101.
329. Gillies, E. R.; Dy, E.; Frechet, J. M. J.; Szoka, F. C. Biological evaluation of polyester dendrimer: Poly(ethylene oxide) "Bow-Tie" hybrids with tunable molecular weight and architecture. Mol. Pharmaceutics 2005, 2, 129-138.
330. Kunzmann, A.; Andersson, B.; Thurnherr, T.; Krug, H.; Scheynius, A.; Fadeel, B. Toxicology of engineered nanomaterials: Focus on biocompatibility, biodistribution and biodegradation. Biochim. Biophys. Acta, Gen. Subj. 2011, 1810, 361-373.
331. Semmler-Behnke, M.; Kreyling, W. G.; Lipka, J.; Fertsch, S.; Wenk, A.; Takenaka, S.; Schmid, G.; Brandau, W. Biodistribution of 1.4-and 18-nm Gold Particles in Rats. Small 2008, 4, 2108-2111.
332. Anderson, J. M.; Shive, M. S. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Delivery Rev. 2012, 64, 72-82.
333. Liu, J.; Jiang, Z. Z.; Zhang, S. M.; Liu, C.; Gross, R. A.; Kyriakides, T. R.; Saltzman, W. M. Biodegradation, biocompatibility, and drug delivery in poly (omega-pentadecalactone-co-p-dioxanone) copolyesters. Biomaterials 2011, 32, 6646-6654.
334. Doherty, G. J.; McMahon, H. T. Mechanisms of Endocytosis. Annu. Rev. Biochem. 2009, 78, 857-902.
335. Sahay, G.; Alakhova, D. Y.; Kabanov, A. V. Endocytosis of nanomedicines. J. Controlled Release 2010, 145, 182-195.
336. Koch, M.; Holt, M. Coupling exo- and endocytosis: An essential role for PIP2 at the synapse. Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 2012, 1821, 1114-1132.
337. Li, Y. H.; Wang, J.; Wientjes, M. G.; Au, J. L. S. Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor. Adv. Drug Delivery Rev. 2012, 64, 29-39.
338. Champion, J. A.; Walker, A.; Mitragotri, S. Role of particle size in phagocytosis of polymeric microspheres. Pharm. Res. 2008, 25, 1815-1821.
339. Roth, T. F.; Porter, K. R. Yolk Protein Uptake in the Oocyte of the Mosquito Aedes Aegypti. L. J. Cell Biol. 1964, 20, 313-332.
340. Rothberg, K. G.; Heuser, J. E.; Donzell, W. C.; Ying, Y. S.; Glenney, J. R.; Anderson, R. G. W. Caveolin, a Protein-Component of Caveolae Membrane Coats. Cell 1992, 68, 673-682.
341. Mayor, S.; Pagano, R. E. Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol. 2007, 8, 603-612.
342. Frick, M.; Bright, N. A.; Riento, K.; Bray, A.; Merrified, C.; Nichols, B. J. Coassembly of flotillins induces formation of membrane microdomains, membrane curvature, and vesicle budding. Curr. Biol. 2007, 17, 1151-1156.
343. Kerr, M. C.; Teasdale, R. D. Defining Macropinocytosis. Traffic 2009, 10, 364-371.
344. Orth, J. D.; McNiven, M. A. Get off my back! Rapid receptor internalization through circular dorsal ruffles. Cancer Res. 2006, 66, 11094-11096.
345. Overholtzer, M.; Mailleux, A. A.; Mouneimne, G.; Normand, G.; Schnitt, S. J.; King, R. W.; Cibas, E. S.; Brugge, J. S. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 2007, 131, 966-979.
346. Douglas, K. L.; Piccirillo, C. A.; Tabrizian, M. Cell linedependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors. Eur. J. Pharm. Biopharm. 2008, 68, 676-687.
347. Bertrand, N.; Leroux, J. C. The journey of a drug-carrier in the body: an anatomo-physiological perspective. J. Controlled Release 2012, 161, 152-163.
348. Mangoni, A. A.; Jackson, S. H. D. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br. J. Clin. Pharmacol. 2004, 57, 6-14.
349. Moghimi, S. M.; Davis, S. S. Innovations in Avoiding Particle Clearance from Blood by Kupffer Cells - Cause for Reflection. Crit. Rev. Ther. Drug Carrier Syst. 1994, 11, 31-59.
350. Fang, J.; Nakamura, H.; Maeda, H. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Delivery Rev. 2011, 63, 136-151.
351. Yadav, K. S.; Chuttani, K.; Mishra, A. K.; Sawant, K. K. Effect of Size on the Biodistribution and Blood Clearance of Etoposide- Loaded PLGA Nanoparticles. PDA J. Pharm. Sci. Technol. 2011, 65, 131-139.
352. Zhang, J. S.; Liu, F.; Huang, L. Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity. Adv. Drug Delivery Rev. 2005, 57, 689-698.
353. Levchenko, T. S.; Rammohan, R.; Lukyanov, A. N.; Whiteman, K. R.; Torchilin, V. P. Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating. Int. J. Pharm. 2002, 240, 95-102.
354. Ernsting, M. J.; Tang, W. L.; MacCallum, N. W.; Li, S. D. Preclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse models. Biomaterials 2012, 33, 1445-1454.
355. Zhang, X. D.; Wu, D.; Shen, X.; Chen, J.; Sun, Y. M.; Liu, P. X.; Liang, X. J. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials 2012, 33, 6408-6419.
356. Vonarbourg, A.; Passirani, C.; Saulnier, P.; Simard, P.; Leroux, J. C.; Benoit, J. P. Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. J. Biomed. Mater. Res., Part A 2006, 78A, 620-628.
357. Hamad, I.; Al-Hanbali, O.; Hunter, A. C.; Rutt, K. J.; Andresen, T. L.; Moghimi, S. M. Distinct Polymer Architecture Mediates Switching of Complement Activation Pathways at the Nanosphere- Serum Interface: Implications for Stealth Nanoparticle Engineering. ACS Nano 2010, 4, 6629-6638.
358. Bhadra, D.; Bhadra, S.; Jain, S.; Jain, N. K. A PEGylated dendritic nanoparticulate carrier of fluorouracil. Int. J. Pharm. 2003, 257, 111-124.
359. Kim, K.; Kim, J. H.; Park, H.; Kim, Y. S.; Park, K.; Nam, H.; Lee, S.; Park, J. H.; Park, R. W.; Kim, I. S.; Choi, K.; Kim, S. Y.; Park, K.; Kwon, I. C. Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring. J. Controlled Release 2010, 146, 219-227.
360. Dufort, S.; Sancey, L.; Coll, J. L. Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution. Adv. Drug Delivery Rev. 2012, 64, 179-189.
361. Florence, A. T. Reductionism and complexity in nanoparticlevectored drug targeting. J. Controlled Release 2012, 161, 399-402.
362. Lutolf, M. P.; Hubbell, J. A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 2005, 23, 47-55.
363. Lee, S. H.; Moon, J. J.; West, J. L. Three-dimensional micropatterning of bioactive hydrogels via two-photon laser scanning photolithography for guided 3D cell migration. Biomaterials 2008, 29, 2962-2968.
364. Hu, M.; Kurisawa, M.; Deng, R.; Teo, C. M.; Schumacher, A.; Thong, Y. X.; Wang, L.; Schumacher, K. M.; Ying, J. Y. Cell immobilization in gelatin-hydroxyphenylpropionic acid hydrogel fibers. Biomaterials 2009, 30, 3523-3531.
365. Mitchell, S. B.; Sanders, J. E. A unique device for controlled electrospinning. J. Biomed. Mater. Res., Part A 2006, 78A, 110-120.
366. Fleige, E.; Quadir, M. A.; Haag, R. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: Concepts and applications. Adv. Drug Delivery Rev. 2012, 64, 866-884.
367. Oh, N. M.; Oh, K. T.; Youn, Y. S.; Lee, D. K.; Cha, K. H.; Lee, D. H.; Lee, E. S. Poly(l-aspartic acid) nanogels for lysosome-selective antitumor drug delivery. Colloids Surf., B 2013, 101, 298-306.
368. Oh, N. M.; Oh, K. T.; Youn, Y. S.; Lee, D. K.; Cha, K. H.; Lee, D. H.; Lee, E. S. Poly(l-aspartic acid) nanogels for lysosome-selective antitumor drug delivery. Colloids Surf., B 2013, 101, 298-306.